PL2788009T3 - Ssacze płodowe komórki płuc i ich zastosowanie terapeutyczne - Google Patents

Ssacze płodowe komórki płuc i ich zastosowanie terapeutyczne

Info

Publication number: PL2788009T3
Authority: PL; Poland
Prior art keywords: same; therapeutic use; pulmonary cells; mammalian fetal; fetal pulmonary
Prior art date: 2011-12-08

Application number

PL12813990.4T

Other languages

English (en)

Inventor

Yair Reisner

Elias Shezen

Chava Rosen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-12-08

Filing date

2012-12-06

Publication date

2016-11-30

2012-12-06 Application filed filed Critical

2016-11-30 Publication of PL2788009T3 publication Critical patent/PL2788009T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0688—Cells from the lungs or the respiratory tract

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Cell Biology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Developmental Biology & Embryology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Virology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Physiology (AREA)
General Engineering & Computer Science (AREA)
Dermatology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)

PL12813990.4T 2011-12-08 2012-12-06 Ssacze płodowe komórki płuc i ich zastosowanie terapeutyczne PL2788009T3 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201161568240P	2011-12-08	2011-12-08

Publications (1)

Publication Number	Publication Date
PL2788009T3 true PL2788009T3 (pl)	2016-11-30

Family

ID=47557423

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL12813990.4T PL2788009T3 (pl)	2011-12-08	2012-12-06	Ssacze płodowe komórki płuc i ich zastosowanie terapeutyczne

Country Status (19)

Country	Link
US (1)	US9833482B2 (pl)
EP (2)	EP3034087B1 (pl)
JP (1)	JP2015500279A (pl)
KR (1)	KR20140102730A (pl)
CN (1)	CN104105493A (pl)
AU (1)	AU2012348574A1 (pl)
CA (1)	CA2857930A1 (pl)
ES (2)	ES2587876T3 (pl)
HK (1)	HK1202809A1 (pl)
HU (1)	HUE030541T2 (pl)
IL (1)	IL233022A (pl)
MX (1)	MX2014006756A (pl)
PH (1)	PH12014501309A1 (pl)
PL (1)	PL2788009T3 (pl)
PT (1)	PT2788009T (pl)
RU (1)	RU2014127338A (pl)
SG (1)	SG11201402902VA (pl)
WO (1)	WO2013084190A1 (pl)
ZA (1)	ZA201404958B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2636503C2 (ru)	2011-09-08	2017-11-23	Иеда Рисеч Энд Девелопмент Ко. Лтд.	Т-клетки центральной памяти против третьей стороны, способы их получения и их применение в трансплантации и лечении заболеваний
PL2788009T3 (pl)	2011-12-08	2016-11-30		Ssacze płodowe komórki płuc i ich zastosowanie terapeutyczne
CN104977414B (zh) *	2014-04-09	2016-09-28	上海交通大学医学院	鉴定骨髓中是否存在保护白血病干细胞微环境的试剂盒及其应用
WO2016203477A1 (en)	2015-06-18	2016-12-22	Yeda Research And Development Co. Ltd.	Conditioning protocols and use of same for tissue regeneration
PL3322424T3 (pl)	2015-07-16	2024-03-04	Yeda Research And Development Co., Ltd.	Zastosowanie centralnych limfocytów t pamięci przeciwko stronie trzeciej
ES2886627T3 (es)	2016-05-22	2021-12-20	Yeda Res & Dev	Métodos de uso de células pulmonares para trasplante e inducción de tolerancia
CN110392736A (zh)	2017-01-18	2019-10-29	耶达研究及发展有限公司	遗传修饰的反抑细胞及其在免疫治疗中的用途
US10751368B2 (en)	2017-01-18	2020-08-25	Yeda Research And Development Co. Ltd.	Methods of transplantation and disease treatment
EP3704225B1 (en) *	2017-10-27	2023-10-11	Alis Pharma Ltd.	Fetal tissue extract, methods for producing the extract, and the use thereof
CN109529123B (zh) *	2018-11-08	2021-02-19	中国人民解放军第四军医大学	水凝胶、纳米纤维支架与皮肤细胞层层组装的血管化全层组织工程皮肤及其制备方法
EP3747992A1 (en)	2019-06-04	2020-12-09	Medizinische Hochschule Hannover	Compositions and process for integrating cells into epithelium
CN111518761B (zh) *	2020-05-25	2022-04-29	青岛瑞思德生物科技有限公司	一种间充质干细胞体外筛选、激活、扩增、冻存及其细胞库建立的方法
CN118696122A (zh)	2021-12-08	2024-09-24	耶达研究及发展有限公司	用于肺再生的多能肺祖细胞

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL154600B (nl)	1971-02-10	1977-09-15	Organon Nv	Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl)	1970-11-10	1977-09-15	Organon Nv	Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl)	1970-12-28	1977-09-15	Organon Nv	Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en)	1971-06-21	1975-08-26	Biological Developments	Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en)	1971-09-01	1974-12-10	W Dreyer	Immunological reagent and radioimmuno assay
US3867517A (en)	1971-12-21	1975-02-18	Abbott Lab	Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl)	1972-05-11	1983-06-01	Akzo Nv	Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en)	1973-03-12	1974-11-26	H Mcconnell	Process for assaying for biologically active molecules
US3935074A (en)	1973-12-17	1976-01-27	Syva Company	Antibody steric hindrance immunoassay with two antibodies
US3996345A (en)	1974-08-12	1976-12-07	Syva Company	Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en)	1974-09-19	1977-07-05	The Board Of Trustees Of Leland Stanford Junior University	Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en)	1975-11-13	1976-10-05	General Electric Company	Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en)	1976-10-26	1978-07-04	Corning Glass Works	Reverse sandwich immunoassay
US4879219A (en)	1980-09-19	1989-11-07	General Hospital Corporation	Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en)	1984-04-12	1991-04-30	The General Hospital Corporation	Multiepitopic immunometric assay
US4666828A (en)	1984-08-15	1987-05-19	The General Hospital Corporation	Test for Huntington's disease
US4683202A (en)	1985-03-28	1987-07-28	Cetus Corporation	Process for amplifying nucleic acid sequences
US4801531A (en)	1985-04-17	1989-01-31	Biotechnology Research Partners, Ltd.	Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5004681B1 (en)	1987-11-12	2000-04-11	Biocyte Corp	Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
US5192553A (en)	1987-11-12	1993-03-09	Biocyte Corporation	Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5272057A (en)	1988-10-14	1993-12-21	Georgetown University	Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en)	1989-08-25	1993-03-09	Genetype Ag	Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en)	1992-07-20	1994-01-25	The Trustees Of The University Of Pennsylvania	Modified avidin-biotin technique
DE69534151T2 (de)	1994-02-22	2006-01-12	Nippon Telegraph And Telephone Corp.	Gefriergetrocknete Blutzellen, Stammzellen und Plättchen und Verfahren zu deren Herstellung
US6204053B1 (en)	1994-11-08	2001-03-20	Diacrin, Inc.	Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
US6110459A (en)	1997-05-28	2000-08-29	Mickle; Donald A. G.	Transplants for myocardial scars and methods and cellular preparations
US5955257A (en)	1997-10-21	1999-09-21	Regents Of The University Of Minnesota	Infusible grade short-term cell storage medium for mononuclear cells
US8609412B2 (en) *	1999-08-05	2013-12-17	Regents Of The University Of Minnesota	Mapc generation of lung tissue
EP1099754A1 (en) *	1999-11-10	2001-05-16	Universiteit Leiden	Mesenchymal stem cells and/or progenitor cells, their isolation and use
US20040136972A1 (en)	2001-09-07	2004-07-15	Yeda Research And Development Co. Ltd.	Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
US20030096016A1 (en) *	2001-09-07	2003-05-22	Yeda Research And Development Co. Ltd.	Methods of kidney transplantation utilizing developing nephric tissue
US20030215942A1 (en)	2002-02-14	2003-11-20	Stemcyte, Inc.	Undesignated allogeneic stem cell bank
EP1490480B1 (en)	2002-03-15	2016-02-03	University of North Carolina at Chapel Hill	Primitive and proximal hepatic stem cells
GB0304799D0 (en)	2003-03-03	2003-04-09	Glaxosmithkline Biolog Sa	Novel method
WO2006038211A2 (en)	2004-10-04	2006-04-13	Yeda Research And Development Co. Ltd.	Disease treatment via developing non-syngeneic graft transplantation
US8628964B2 (en) *	2006-10-11	2014-01-14	Drexel University	Fetal pulmonary cells and uses thereof
US20100034791A1 (en) *	2007-02-14	2010-02-11	Drexel University	Engineered Lung Tissue Construction for High Throughput Toxicity Screening and Drug Discovery
EP2624847B1 (en) *	2010-10-05	2017-09-13	AAL Scientifics, Inc.	Human lung stem cells and uses thereof
PL2788009T3 (pl)	2011-12-08	2016-11-30		Ssacze płodowe komórki płuc i ich zastosowanie terapeutyczne
BR112014015959A8 (pt)	2011-12-22	2017-07-04	Yeda Res & Dev	método para o tratamento de um indivíduo em necessidade de um enxerto de célula não singênico ou tecido, método para tratar um indivíduo que precisa de um transplante de célula hematopoiética imatura, método para induzir a tolerância específica do doador em um indivíduo que precisa de uma célula não singênica ou enxerto de tecido, e método para tratar um indivíduo que precisa de uma célula não singênica ou enxerto de tecido
WO2016203477A1 (en)	2015-06-18	2016-12-22	Yeda Research And Development Co. Ltd.	Conditioning protocols and use of same for tissue regeneration

2012
- 2012-12-06 PL PL12813990.4T patent/PL2788009T3/pl unknown
- 2012-12-06 AU AU2012348574A patent/AU2012348574A1/en not_active Abandoned
- 2012-12-06 PT PT128139904T patent/PT2788009T/pt unknown
- 2012-12-06 WO PCT/IB2012/057042 patent/WO2013084190A1/en not_active Ceased
- 2012-12-06 EP EP16151376.7A patent/EP3034087B1/en active Active
- 2012-12-06 EP EP12813990.4A patent/EP2788009B1/en active Active
- 2012-12-06 HU HUE12813990A patent/HUE030541T2/en unknown
- 2012-12-06 MX MX2014006756A patent/MX2014006756A/es unknown
- 2012-12-06 KR KR1020147018702A patent/KR20140102730A/ko not_active Withdrawn
- 2012-12-06 CN CN201280069291.9A patent/CN104105493A/zh active Pending
- 2012-12-06 US US14/363,814 patent/US9833482B2/en active Active
- 2012-12-06 CA CA2857930A patent/CA2857930A1/en not_active Abandoned
- 2012-12-06 JP JP2014545442A patent/JP2015500279A/ja active Pending
- 2012-12-06 SG SG11201402902VA patent/SG11201402902VA/en unknown
- 2012-12-06 HK HK15103466.2A patent/HK1202809A1/xx unknown
- 2012-12-06 RU RU2014127338A patent/RU2014127338A/ru not_active Application Discontinuation
- 2012-12-06 ES ES12813990.4T patent/ES2587876T3/es active Active
- 2012-12-06 ES ES16151376.7T patent/ES2673471T3/es active Active
2014
- 2014-06-08 IL IL233022A patent/IL233022A/en active IP Right Grant
- 2014-06-09 PH PH12014501309A patent/PH12014501309A1/en unknown
- 2014-07-07 ZA ZA2014/04958A patent/ZA201404958B/en unknown

Also Published As

Publication number	Publication date
HUE030541T2 (en)	2017-05-29
IL233022A (en)	2017-12-31
EP2788009B1 (en)	2016-05-25
IL233022A0 (en)	2014-07-31
EP3034087B1 (en)	2018-03-14
ES2673471T3 (es)	2018-06-22
PH12014501309A1 (en)	2014-09-15
AU2012348574A1 (en)	2014-07-24
ZA201404958B (en)	2015-05-27
WO2013084190A1 (en)	2013-06-13
CA2857930A1 (en)	2013-06-13
EP3034087A1 (en)	2016-06-22
CN104105493A (zh)	2014-10-15
JP2015500279A (ja)	2015-01-05
ES2587876T3 (es)	2016-10-27
SG11201402902VA (en)	2014-07-30
RU2014127338A (ru)	2016-02-10
KR20140102730A (ko)	2014-08-22
US20140356335A1 (en)	2014-12-04
EP2788009A1 (en)	2014-10-15
MX2014006756A (es)	2015-03-09
NZ627071A (en)	2015-11-27
HK1202809A1 (en)	2015-10-09
PT2788009T (pt)	2016-08-31
US9833482B2 (en)	2017-12-05

Publication	Publication Date	Title
ZA201404958B (en)	2015-05-27	Mammalian fetal pulmonary cells and therapeutic use of same
SG10201608341XA (en)	2016-11-29	Cd40l expressing mammalian cells and their use
PT2683815E (pt)	2015-09-18	Derivados de piridinona como inibidores da transglutaminase tecidular
SG2014011282A (en)	2014-06-27	Anode battery materials and methods of making the same
EP3527584B8 (en)	2020-12-16	Medical use of cells comprising anti-ny-eso-1 t cell receptors
IL237527A0 (en)	2015-04-30	Devices and methods for growing cells
IL228031B (en)	2018-02-28	Adno vectors for gene therapy in choroideremia
EP2721019A4 (en)	2014-11-19	THERAPEUTIC ACTIVE COMPOSITIONS AND METHOD FOR THEIR USE
LT2683731T (lt)	2019-07-10	C4-monometiltriterpenoido dariniai ir jų panaudojimo būdai
SG10201606745XA (en)	2016-10-28	Therapeutics using adipose cells and cell secretions
SI3321355T1 (sl)	2021-11-30	Postopki in sestavki za klinično izpeljavo alogenske celice in terapevtske uporabe
IL237638B (en)	2020-04-30	Heteroaryl c17 derivatives of olanolic acid and methods of using them
PT2729000T (pt)	2023-04-10	Um método para o armazenamento prolongado de glóbulos vermelhos
EP2555801A4 (en)	2014-02-26	SELECTION AND USE OF HOST CELLS FOR THE MANUFACTURE OF GLYCOPROTEINS
GB201100180D0 (en)	2011-02-23	Tumour cell and tissue culture
IL226666B (en)	2018-10-31	Methods of generating corneal cells and cell populations comprising same
GB201200458D0 (en)	2012-02-22	Methods of preparing cells and compositions
IL228708A0 (en)	2013-12-31	Analogues of epoxyeicostrienoic acid and methods for their preparation and use
SG11201502497RA (en)	2015-04-29	Sebocyte cell culturing and methods of use
EP2616073A4 (en)	2015-02-18	INHIBITORS OF IMMERSION OF VIRUSES IN MAMMALIAN HOST CELLS
SG11201401038VA (en)	2014-07-30	Isolating and therapeutic use of perivascular medicinal cells
SG11201406771PA (en)	2014-11-27	Stem cell preparations and methods of use
TWM401215U (en)	2011-04-01	Parallel structure of battery and battery set having the structure
BR112014014033A2 (pt)	2017-07-11	células pulmonares fetais de mamíferos e uso terapêutico das mesmas
ZA201308320B (en)	2015-01-28	Epoxyeicosatrienoic acid analogs and methods of making and using the same